Federal Antimonopoly Service: “The Government has no clear information on counterfeit medications in Russia”
«The government has no clear information on the volume of counterfeit and illegal pharmaceutical products," Sergei Maximov, deputy head of the legal department of the Federal Antimonopoly Service, said at the press conference on 5 February during his report on «Pharmaceutical piracy in Russia». The report was prepared by the Institute of State and Law of the Russian Academy of Sciences, the Association of Law Enforcement Agencies and Security Services of the Russian Federation, the Public Board on Healthcare and Social Protection, Scientific Center of Quality Control and the Union of Professional Pharmaceutical Organizations. «There is no special statistics body in Russia which has to accumulate the information on all forms of pharmaceutical piracy. That is why all the estimates are of expert character only», Maximov said. According to experts, the fake medications account for up to 12% of Russian pharmaceutical market.
The reasons were explained by Russia’s lagging behind many advanced countries in drug manufacturing and circulation, the high corruption level of in the regulatory, law enforcement and healthcare authorities, the insufficient legal regulations, etc.